# A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine

> **NCT00390676** · PHASE1 · COMPLETED · sponsor: **Adherex Technologies, Inc.**

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** ADH -1 and carboplatin
- **DRUG:** ADH -1 and docetaxel
- **DRUG:** ADH -1 and capecitabine

## Key facts

- **NCT ID:** NCT00390676
- **Lead sponsor:** Adherex Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** —
- **Final completion:** 2009-11
- **Target enrollment:** — (—)
- **Last updated:** 2010-12-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00390676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00390676, "A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00390676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*